CELLULAR DYNAMICS INTERNATIONAL, INC. STOCK OPTION AGREEMENTStock Option Agreement • May 17th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances) • Wisconsin
This Option Agreement, entered into as of __________________ (the “Date of Grant”), is between Cellular Dynamics International, Inc., a Wisconsin corporation (the “Company”), and [NAME] (the “Participant”). All terms used herein and not otherwise defined shall have the same meaning as set forth in the Company’s 2013 Equity Incentive Plan (the “Plan”).
AMENDMENT TO LEASE AGREEMENTLease Agreement • May 17th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)
THIS AMENDMENT TO LEASE AGREEMENT ("Amendment") is made as of May 6, 2013 (the “Effective Date”), by and between UNIVERSITY RESEARCH PARK, INCORPORATED, a Wisconsin non-stock corporation (hereinafter referred to as "Landlord"), and CELLULAR DYNAMICS INTERNATIONAL, INC., a Wisconsin corporation (hereinafter referred to as "Tenant").
Cellular Dynamics International, Inc. University Research Park Madison, WI 53711Consulting Agreement • May 17th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)
This letter (when fully executed and delivered by you as contemplated below, this “Agreement”) will confirm our understanding, effective as of the date of closing of the IPO (as defined below) (the “Effective Date”), regarding the amendment of the Consulting Agreement and the 2010 Letter Agreement and your undertakings regarding the license or transfer to the Company of certain intellectual property in connection with, and as consideration for, the grant to you of an option for the purchase of 1,462,500 shares of the Company’s common stock (“Common Stock”) under the Company’s 2013 Equity Incentive Plan (the “Plan”), as further described in this paragraph. Such option grant would be made on, or on the day immediately before, the Effective Date, would be subject to the condition for the benefit of the Company that the IPO closes, and would provide for an exercise price per share equal to the price per share at which Common Stock is sold to the public in the IPO. The number of shares spec
FOURTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 17th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)
This First Amendment (this “Amendment”) amends that certain Fourth Amended and Restated Registration Rights Agreement, dated as of November 1, 2012 (the “Agreement”), by and among by and among CELLULAR DYNAMICS INTERNATIONAL, INC., a Wisconsin corporation (the “Company”), and the individuals and entities who have executed a counterpart signature page hereto (each individually an “Amending Preferred Shareholder” and collectively the “Amending Preferred Shareholders”). Capitalized terms used herein without definition shall have the meanings ascribed to them in the Agreement
SECOND AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • May 17th, 2013 • Cellular Dynamics International, Inc. • Biological products, (no disgnostic substances)
This Second Amendment (“Second Amendment”) to the Supply Agreement is by and between Cellular Dynamics International, Inc. (“CDI”) and Hoffmann-La Roche Inc. (“Roche”).
